Lfb Biotechnologies S.a.s.u. - Net Worth and Insider Trading
Lfb Biotechnologies S.a.s.u. Net Worth
The estimated net worth of Lfb Biotechnologies S.a.s.u. is at least $285 Million dollars as of 2025-07-23. Lfb Biotechnologies S.a.s.u. is the 10% Owner of TG Therapeutics Inc and owns about 7,614,855 shares of TG Therapeutics Inc (TGTX) stock worth over $285 Million. Details can be seen in Lfb Biotechnologies S.a.s.u.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lfb Biotechnologies S.a.s.u. has not made any transactions after 2015-02-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lfb Biotechnologies S.a.s.u.
Lfb Biotechnologies S.a.s.u. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lfb Biotechnologies S.a.s.u. owns 1 companies in total, including TG Therapeutics Inc (TGTX) .
Click here to see the complete history of Lfb Biotechnologies S.a.s.u.’s form 4 insider trades.
Insider Ownership Summary of Lfb Biotechnologies S.a.s.u.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TGTX | TG Therapeutics Inc | 2015-02-17 | 10 percent owner |
Lfb Biotechnologies S.a.s.u. Latest Holdings Summary
Lfb Biotechnologies S.a.s.u. currently owns a total of 1 stock. Lfb Biotechnologies S.a.s.u. owns 7,614,855 shares of TG Therapeutics Inc (TGTX) as of February 17, 2015, with a value of $285 Million.
Latest Holdings of Lfb Biotechnologies S.a.s.u.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TGTX | TG Therapeutics Inc | 2015-02-17 | 7,614,855 | 37.37 | 284,567,131 |
Holding Weightings of Lfb Biotechnologies S.a.s.u.
Lfb Biotechnologies S.a.s.u. Form 4 Trading Tracker
According to the SEC Form 4 filings, Lfb Biotechnologies S.a.s.u. has made a total of 0 transactions in TG Therapeutics Inc (TGTX) over the past 5 years. The most-recent trade in TG Therapeutics Inc is the acquisition of 114,855 shares on February 17, 2015, which cost Lfb Biotechnologies S.a.s.u. around $750,003.
Insider Trading History of Lfb Biotechnologies S.a.s.u.
- 1
Lfb Biotechnologies S.a.s.u. Trading Performance
GuruFocus tracks the stock performance after each of Lfb Biotechnologies S.a.s.u.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lfb Biotechnologies S.a.s.u. is 19.44%. GuruFocus also compares Lfb Biotechnologies S.a.s.u.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Lfb Biotechnologies S.a.s.u. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lfb Biotechnologies S.a.s.u.'s insider trading performs compared to the benchmark.
Performance of Lfb Biotechnologies S.a.s.u.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 29.09 | | | | | |
| Relative Return to S&P 500(%) | 30.33 | | | | | |
Lfb Biotechnologies S.a.s.u. Ownership Network
Ownership Network List of Lfb Biotechnologies S.a.s.u.
Ownership Network Relation of Lfb Biotechnologies S.a.s.u.
Lfb Biotechnologies S.a.s.u. Owned Company Details
What does TG Therapeutics Inc do?
Who are the key executives at TG Therapeutics Inc?
Lfb Biotechnologies S.a.s.u. is the 10 percent owner of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .
TG Therapeutics Inc (TGTX) Insider Trades Summary
Over the past 18 months, Lfb Biotechnologies S.a.s.u. made no insider transaction in TG Therapeutics Inc (TGTX). Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 35,933 shares made by Sagar Lonial , a net sale of 47,000 shares made by Laurence N Charney , and a net sale of 30,000 shares made by Yann Echelard .
In summary, during the past 3 months, insiders sold 10,000 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 134,291 shares of TG Therapeutics Inc (TGTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 134,291 shares.
TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TG Therapeutics Inc Insider Transactions
Lfb Biotechnologies S.a.s.u. Mailing Address
Above is the net worth, insider trading, and ownership report for Lfb Biotechnologies S.a.s.u.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Lfb Biotechnologies S.a.s.u.'s mailing address is: Courtaboeuf I0 91958.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
